I
NBIX icon

InceptionR’s Neurocrine Biosciences NBIX Stock Holding History

InceptionR’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
+7,910
New +$1.17M 0.33% 66
2026
Q1 		– Sell
-5,724
Closed -$812K – 812
2025
Q4 		$812K Buy
+5,724
New +$829K 0.23% 165
2025
Q3 		– Sell
-1,910
Closed -$240K – 855
2025
Q2 		$240K Buy
+1,910
New +$219K 0.06% 513
2024
Q3 		– Sell
-5,944
Closed -$818K – 801
2024
Q2 		$818K Buy
+5,944
New +$815K 0.23% 154

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

InceptionR's NBIX Position: Q2 2026 in Review

InceptionR opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 7,910 shares worth $1.33M. The stake represents 0.33% of the portfolio and ranks #66 among its holdings. This is a return to the name: InceptionR previously reported a position in NBIX as recently as Q4 2025.

InceptionR first reported a position in NBIX in Q2 2024 and has held it in 4 quarters since. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • InceptionR held 7,910 shares of Neurocrine Biosciences worth $1.33M as of Q2 2026.
  • Neurocrine Biosciences was a new InceptionR position in Q2 2026.
  • Neurocrine Biosciences made up 0.33% of InceptionR's portfolio in Q2 2026, its #66 holding.
  • InceptionR first reported a position in Neurocrine Biosciences in Q2 2024 and has held it in 4 quarters since.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.